Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 18 de 18
Filtre
1.
Braz. J. Pharm. Sci. (Online) ; 58: e19473, 2022. tab, graf
Article Dans Anglais | LILACS | ID: biblio-1384023

Résumé

Abstract RGX-365 is the main fraction of black ginseng conmprising protopanaxatriol (PPT)-type rare ginsenosides (ginsenosides Rg4, Rg6, Rh4, Rh1, and Rg2). No studies on the antiseptic activity of RGX-365 have been reported. High mobility group box 1 (HMGB1) is recognized as a late mediator of sepsis, and the inhibition of HMGB1 release and recovery of vascular barrier integrity have emerged as attractive therapeutic strategies for the management of sepsis. In this study, we examined the effects of RGX-365 on HMGB1-mediated septic responses and survival rate in a mouse sepsis model. RGX-365 was administered to the mice after HMGB1 challenge. The antiseptic activity of RGX-365 was assessed based on the production of HMGB1, measurement of permeability, and septic mouse mortality using a cecal ligation and puncture (CLP)-induced sepsis mouse model and HMGB1-activated human umbilical vein endothelial cells (HUVECs). We found that RGX-365 significantly reduced HMGB1 release from LPS- activated HUVECs and CLP-induced release of HMGB1 in mice. RGX-365 also restored HMGB1-mediated vascular disruption and inhibited hyperpermeability in the mice. In addition, treatment with RGX-365 reduced sepsis-related mortality in vivo. Our results suggest that RGX- 365 reduces HMGB1 release and septic mortality in vivo, indicating that it is useful in the treatment of sepsis.


Sujets)
Protéine HMGB1/analyse , Panax/effets indésirables , Perméabilité , Sepsie/anatomopathologie , Ginsénosides , Cellules endothéliales de la veine ombilicale humaine/classification , Anti-infectieux locaux/effets indésirables
2.
Korean Journal of Radiology ; : 269-276, 2009.
Article Dans Anglais | WPRIM | ID: wpr-101653

Résumé

OBJECTIVE: We wanted to evaluate the safety and feasibility of ethanol sclerotherapy for treating craniofacial venous malformations (CVMs). MATERIALS AND METHODS: From May 1998 to April 2007, 87 patients (40 men and 47 women; age range, 2-68 years) with CVMs underwent staged ethanol sclerotherapy (range, 1-21 sessions; median number of sessions, 2) by the direct puncture technique. Clinical follow up (range, 0-120 months; mean follow up, 35 months; median follow up, 28 months) was performed for all the patients. Therapeutic outcomes were established by evaluating the clinical outcome of the signs and symptoms in all patients, as well as the degree of devascularization, which was determined on the follow-up imaging, in 71 patients. RESULTS: A total of 305 procedures with the use of ethanol were performed in 87 patients. Follow-up imaging studies were performed for 71 of 87 patients. Twenty-three (32%) of the 71 patients showed excellent outcomes, 37 patients (52%) showed good outcomes and 11 patients (16%) showed poor outcomes. Ethanol sclerotherapy was considered effective for 60 patients. All the minor complications such as bulla (n = 5) healed with only wound dressing and observation. Any major complication such as skin necrosis did not develop. CONCLUSION: Percutaneous ethanol sclerotherapy is an effective, safe treatment for CVMs.


Sujets)
Adolescent , Adulte , Sujet âgé , Enfant , Enfant d'âge préscolaire , Femelle , Humains , Mâle , Adulte d'âge moyen , Jeune adulte , Analgésiques/administration et posologie , Anti-infectieux locaux/effets indésirables , Malformations crâniofaciales/thérapie , Éthanol/effets indésirables , Études de faisabilité , Études de suivi , Douleur/traitement médicamenteux , Études rétrospectives , Solutions sclérosantes/effets indésirables , Sclérothérapie/effets indésirables , Résultat thérapeutique , Anomalies vasculaires/thérapie
5.
Article Dans Anglais | IMSEAR | ID: sea-40871

Résumé

BACKGROUND: Thimerosal or merthiolate is used as an antiseptic and a preservative in topical medicaments, cosmetics, and vaccines. Thimerosal is known to cause delayed type hypersensitivity. However, there is argument about the clinical relevance and risk of using thimerosal-preserved products in thimerosal allergic individuals. OBJECTIVE: Retrospective review of patch test results from the Ramathibodi Hospital patch test clinic to determine the prevalence and relevance of allergic reactions to thimerosal in Thailand. MATERIAL AND METHOD: During a 5-year period, thimerosal was patch tested in all patients tested for possible allergic contact dermatitis. Thimerosal was the second most common allergen causing a positive patch test reaction. RESULTS: Of the 433 patients tested, 46 (10.62%) were positive to thimerosal. However, despite the high prevalence of positive reactions none was clinically relevant to their present dermatitis, none of the patients reported reactions to vaccination or cross-reaction to piroxicam. CONCLUSION: There was a high rate of sensitization to thimerosal in Thai patients, but were of little clinical relevance. The author does not advise thimerosal allergic individuals to avoid vaccination, although the small risk of local dermatitis should be pointed out. The topical use of thimerosal containing antiseptics should be avoided.


Sujets)
Adolescent , Adulte , Anti-infectieux locaux/effets indésirables , Enfant , Enfant d'âge préscolaire , Eczéma de contact allergique/épidémiologie , Femelle , Humains , Mâle , Adulte d'âge moyen , Tests épicutanés , Prévalence , Études rétrospectives , Appréciation des risques , Facteurs de risque , Thaïlande/épidémiologie , Thiomersal/effets indésirables , Facteurs temps
9.
Pesqui. bras. odontopediatria clín. integr ; 4(1): 33-38, jan.-abr. 2004. ilus, tab
Article Dans Portugais | LILACS, BBO | ID: biblio-872746

Résumé

O objetivo deste estudo foi avaliar a atividade antibacteriana deprodutos fitoterápicos comerciais frente aos microrganismoscariogênicos: S. mutans (ATCC 2575); S. sobrinus (ATCC27607); S. sanguis (ATCC 10557) e L. casei (ATCC 4646). Osprodutos utilizados foram: Água Rabelo« - (A); Malvatricin« - (B);Mel Rosado« - (C); Apis Flora« - (D); Fitogargarejo« - (E )e Óleode Copahyba« - (F). Empregou-se a técnica de Concentração inibitória mínima (CIM); cada linhagem bacteriana foi reativada em caldo Tryptic Soy Broth, incubada a 370C por 24 horas em microaerofilia e semeadas em meio de cultura Ágar Mueller Hintõn pela técnica de inundação. Os produtos fitoterápicos foram empregados em concentrações de 100 por cento à 0,19 por cento e os halos de inibição mensurados. Verificou-se para a linhagem S.mutans as CIMs de 0,19 por cento; 12,5 por cento; 1,56 por cento; 3,12 por cento e 0,78 por cento para os produtos B, C, D, E e F respectivamente. Para a linhagem S.sanguis as CIMs observadas foram de 0,39 por cento; 25 por cento; 1,56 por cento;6,25 por cento e 0,78 por cento em B, C, D, E e F respectivamente. Sobre o S.sobrinus apenas o produto B mostrou atividade antibacterianana concentração de 0,19 porcento. Em relação ao L. casei os produtos B, D, E e F apresentaram respectivamente CIMs de 0,19 por cento;0,78 por cento; 0,78 por cento e 6,25 por cento. O produto B apresentou os maiores halos frente a todas as linhagens. Concluiu-se que os produtos tiveram desempenhos variados, tendo o Malvatricin« obtido amelhor CIM frente a todas as linhagens, bem como os maiores espectros de inibição e Água Rabelo« não apresentou atividade antibacteriana


Sujets)
Humains , Adulte , Bactéries , Médicaments Phytothérapeutiques , Microbiologie , Odontologie préventive/enseignement et éducation , Anti-infectieux locaux/analyse , Anti-infectieux locaux/effets indésirables , Anti-infectieux locaux/pharmacologie , Anti-infectieux locaux , Anti-infectieux locaux/usage thérapeutique , Techniques in vitro
10.
Journal of Korean Medical Science ; : 289-290, 2004.
Article Dans Anglais | WPRIM | ID: wpr-67691

Résumé

Benzalkonium chloride (BAC) is commonly used as a bactericidal preservative in nebulizer solutions, and can cause paradoxical onchoconstriction following nebulizing therapy in some asthmatics. We describe a case of anaphylactic shock in a 23-yr-old asthmatic woman following an intradermal skin test with a salbutamol solution containing BAC. Since she complained of cough and dyspnea after inhalation therapy with a nebulizer solution, we conducted an intradermal skin test using the same solution, which contained BAC. About 10 min later, the patient reported dizziness, palpitations, and dyspnea. On examination, tachycardia, tachypnea, and hypotension were found. She was resuscitated with a subcutaneous injection of epinephrine and an infusion of saline. One month later, we conducted a bronchial provocation test with BAC, and she showed a positive response.


Sujets)
Adulte , Femelle , Humains , Anaphylaxie/induit chimiquement , Antiasthmatiques/administration et posologie , Anti-infectieux locaux/effets indésirables , Asthme/traitement médicamenteux , Composés de benzalkonium/effets indésirables , Nébuliseurs et vaporisateurs
11.
Pesqui. odontol. bras ; 17(2): 109-112, Apr.-Jun. 2003. tab
Article Dans Anglais | LILACS | ID: lil-347419

Résumé

The vascular changes in the subcutaneous connective tissue of rats induced by dentin bonding systems (one step) was studied and compared to those induced by saline solution (negative control) and Furacin (positive control), during the exudative phase of the inflammatory process. Twenty mg/kg of Evan's blue were injected intravenously in the vein of the rats' penises; 0.1 ml of each substance tested was inoculated in the subcutaneous tissue. After a 3 hour period the animals were sacrificed and their skins were excised and punched out with a standard steel 2.5 cm in diameter. The specimens were immediately immersed in 8 ml of formamide and taken to a double boiler for 72 hours at 37ºC, to remove the dye. The liquid containing the overflowed dye was filtered, analyzed in the spectrophotometer (620 nm) and classified according to the criteria established by Nagem-Filho, Pereira (1976). After statistical analysis, the irritative potential of the substances was ranked as follows: Furacin (severe) > Single Bond and Bond 1 (moderate - no significant differences between the dentin bonding systems tested) > saline solution (not significant as regards the irritation degree)


Sujets)
Animaux , Rats , Agents de collage dentinaire/effets indésirables , Tissu sous-cutané/effets des médicaments et des substances chimiques , Anti-infectieux locaux/effets indésirables , Anti-infectieux locaux/pharmacocinétique , Méthacrylate bisphénol A-glycidyl/effets indésirables , Méthacrylate bisphénol A-glycidyl/pharmacocinétique , Perméabilité capillaire/effets des médicaments et des substances chimiques , Agents de collage dentinaire/pharmacocinétique , Inflammation/métabolisme , Nitrofural/effets indésirables , Nitrofural/pharmacocinétique , Tissu sous-cutané/vascularisation
12.
Bol. méd. Hosp. Infant. Méx ; 57(12): 705-6, dic. 2000.
Article Dans Espagnol | LILACS | ID: lil-286304

Résumé

Introducción. El cloramfenicol oftálmico es un antimicrobiano de amplio espectro que se utiliza muy frecuentemente en salas de expulsión y de urgencias, como profilaxis neonatal y en infecciones superficiales de los ojos; sus efectos adversos son muy raros, uno de ellos es la hipersensibilidad cutánea. Caso clínico. Recién nacido del sexo femenino, sana, obtenida por parto eutócico, sin asfixia y con exploración física normal; que al aplicarle las gotas de cloramfenicol oftálmico como profilaxis neonatal presentó edema y eritema bipalpebral bilateral inmediato y eritema en miembros inferiores, desapareciendo espontáneamente sin complicaciones. Se comenta la absorción sistémica de las gotas oftálmicas; los efectos adversos que se relacionan con la dosis del medicamento, así como la idiosincrasia del paciente. Conclusión. En la literatura se reporta un caso similar que presentó placas eritematosas en todo el cuerpo. Hay que tener presente, que a pesar de que el cloramfenicol oftálmico es un medicamento muy utilizado, puede producir alteraciones dermatológicas, hematológicas y gastrointestinales, las cuales son raras, debiéndose tener la suspicacia clínica necesaria para detectarlas oportunamente.


Sujets)
Humains , Femelle , Nouveau-né , Eczéma de contact/étiologie , Antibioprophylaxie/effets indésirables , Solutions ophtalmiques/effets indésirables , Anti-infectieux locaux/effets indésirables
13.
Article Dans Anglais | IMSEAR | ID: sea-64774

Résumé

A patient with a large hydatid cyst of the left lobe of the liver developed metabolic acidosis following rather liberal use of cetrimide-chlorhexidine solution as a scolicidal agent. The progress and management of this complication are described in the patient is being reported.


Sujets)
Acidose/induit chimiquement , Adulte , Anti-infectieux locaux/effets indésirables , Antihelminthiques anticestodes/effets indésirables , Composés de cétrimonium/effets indésirables , Chlorhexidine/effets indésirables , Association médicamenteuse , Échinococcose hépatique/traitement médicamenteux , Femelle , Humains
14.
Rev. cuba. plantas med ; 1(1): 30-3, ene.-abr. 1996. tab
Article Dans Espagnol | LILACS | ID: lil-186763

Résumé

Se realizo el estudio de la irritabilidad oftalmica de una solucion compuesta por aceites esenciales de Cymbopogon citratus (DC) Stapf (cana santa) y Plectrantus amboinicus (Lour) Spreng (oregano frances) en base alcoholica, la que presenta efecto antiseptico y fue identificada como solucion CS201. Se utilizo el metodo de Draize y se determino el indice de irritabilidad oftalmica segun el metodo cubano


Sujets)
Animaux , Lapins , Anti-infectieux locaux/effets indésirables , Plantes médicinales , Oeil/effets des médicaments et des substances chimiques
15.
Rev. AMRIGS ; 34(3): 151-4, jul.-set. 1990. tab
Article Dans Portugais | LILACS | ID: lil-95169

Résumé

Estudos recentes têm demonstrado que a aplicaçäo de soluçöes iodadas na pele e mucosas em gestantes e recém-nascidos podem ser absorvidas, causando hipotireoidismo transitório e bócio. Näo havendo estudos comprovando que estas soluçöes utilizadas no coto umbilical possam provocar efeitos na funçai tireoidiana, oa autores realizaram um estudo prospectivo e randomizado em 104 recém-nascidos normais, com idade média de 10,8 ñ 2,7 dias no momento da coleta, dos quais 51 usaram álcool iodado a 1% no coto umbilical (grupo I) e 53 utilizaram álcool etílico a 70- gl (grupo II). As variáveis se distribuíram igualmente nos dois grupos. Dosou-se T4 e TSH por radioimunoensaio. O presente estudo demonstrou que o iodo é absorvido pelo coto umbilical, resultando em aumento do TSH (6,6 ñ 4,6 x 4,7 ñ 3,0; p < 0,02) e diminuiçäo da secreçäo de T4 (11,2 ñ 2,4 x 13,4 ñ 2,9; p < 0,0001), em relaçäo ao grupo-controle. Apesar da alteraçäo significativa da funçäo tireoidiana, näo foi observado nenhum caso com quadro clínico de hipotireoidismo ou bócio. Os autores recomendam a retirada de antissépticos iodados do coto umbilical do recém-nasdcido


Sujets)
Nouveau-né , Humains , Mâle , Femelle , Absorption , Glande thyroide/physiopathologie , Hyperthyroïdie/induit chimiquement , Anti-infectieux locaux/effets indésirables , Cordon ombilical , Prise en charge postnatale
17.
Arq. Centro Estud. Curso Odontol ; 21(1): 53-64, jan.-jun. 1984. ilus
Article Dans Portugais | LILACS, BBO | ID: lil-143440

Résumé

Os autores realizaram uma investigaçäo para determinar os efeitos do paramonoclorofenol canforado e de várias concentraçöes aquosas de paramonoclorofenol (2 por cento, 1 por cento, 0,1 por cento e 0,01 por cento) no tecido conjuntivo subcutâneo de ratos utilizando-se de implantes de esponja polivinílica. Foram realizadas observaçöes bioquímicas e histológicas. De acordo com as observaçöes realizadas pelos autores na presente investigaçäo e com os resultados encontrados na literatura pertinente, pode-se concluir que soluçöes aquosas de paramonoclorofenol a 1 por cento e 2 por cento forneceräo reaçöes texturais mínimas quando desejável o seu uso como medicaçäo intracanal


Sujets)
Animaux , Rats , Traitement de canal radiculaire , Anti-infectieux locaux/effets indésirables , Chlorophénols/usage thérapeutique , Tissu conjonctif/effets des médicaments et des substances chimiques
SÉLECTION CITATIONS
Détails de la recherche